MarketPulse

strategic review

4 articles
BenzingaBenzinga··Lekha Gupta

Victoria's Secret Reviews DailyLook Asset Amid Strong Q4 Results

Victoria's Secret reports 8% sales growth and beat EPS estimates, but initiates strategic review of DailyLook subsidiary, sending shares down 12.91%.
VSCOstrategic reviewguidance
BenzingaBenzinga··Vandana Singh

Theravance Biopharma Crashes 27% After Phase 3 Study Failure

Theravance Biopharma shares plummet 27% after ampreloxetine fails Phase 3 trial; company cuts workforce 50% and reduces expenses 60%.
TBPHstrategic reviewbiotech
BenzingaBenzinga··Vandana Singh

Ensysce Biosciences Stock Jumps on Strategic Review Announcement

Ensysce Biosciences stock surges 58.66% after announcing a strategic review of partnerships, licensing, and asset sales to maximize shareholder value.
ENSCEnsysce Biosciencesstrategic review
The Motley FoolThe Motley Fool··Cory Renauer

Kiltearn Partners Establishes $8M Position in LKQ Amid Strategic Review

Kiltearn Partners invested $8M in LKQ Corporation, making it their 12th largest holding. The timing coincides with LKQ's strategic review and potential divestiture plans.
LKQstrategic reviewinstitutional investment